Amjevita 55513-0411

Generic: Adalimumab-Atto

Product NDC

55513-0411

Manufacturer: Amgen, Inc
Dosage Form: Injection
Route: Subcutaneous
Product Type: Human Prescription Drug
Marketing Start: January 31, 2023
Listing Expires: December 31, 2027
Application: BLA761024

Need to source Amjevita? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Adalimumab	20 mg/.4mL

Drug Class

Tumor Necrosis Factor Blocker [EPC]AntibodiesMonoclonal [CS]

Packaging Options(1)

55513-0411-01

1 SYRINGE in 1 CARTON (55513-411-01) / .4 mL in 1 SYRINGE

View →